Vimarsana
Biggest News Aggregation in the World

Page 27 - Gen Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gen Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gen Li Today - Breaking & Trending Today

Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger - Vimarsana News

Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger

New big data analysis finds growing proportion of younger patients participating in breast cancer clinical trials, with implications for trial design and execution   Boston, USA, 3rd May 2022: New analysis from Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and sol...

Man wanted for allegedly sexually assaulting teen at Markham mall turns himself in to police - Vimarsana News

Man wanted for allegedly sexually assaulting teen at Markham mall turns himself in to police

A man wanted for allegedly sexually assaulting a teenage boy at a mall in Markham has turned himself in, York Regional Police said.

Source: cp24.com
Only 14% of breast cancer trials reached optimal enrolment targets in 2021 - Vimarsana News

Only 14% of breast cancer trials reached optimal enrolment targets in 2021

Only 14% of breast cancer trials reached optimal enrolment targets in 2021, despite being the most studied indication globally.

Source: zenopa.com
Recruitment gaining more rapidly in some groups than others - Vimarsana News

Recruitment gaining more rapidly in some groups than others

Patient data from the clinical solutions company indicates that gains in recruitment of Black participants is outpacing that of patients from other groups.

COVID-19 lessons can apply to hepatitis treatments: Phesi - Vimarsana News

COVID-19 lessons can apply to hepatitis treatments: Phesi

According to the firm, infectious-disease research advancements could be applied to discovering treatments for millions of hepatitis patients globally.